HOME >> MEDICINE >> NEWS
Widely Used Therapy May Not Be Effective In Treatment Of Acute Stroke

General use of anticlotting drugs, like low-molecular-weight (LMW) heparinoids, immediately after a stroke has little effect in producing a good outcome or in preventing a second stroke in most patients, according to the results of a large clinical trial published in the April 22, 1998, issue of The Journal of the American Medical Association. (1)

These results may bring about a change in the way the medical community treats stroke. For many years it has been common practice to administer anticoagulants to patients immediately after a stroke in an effort to limit brain injury and to prevent recurrent strokes. However, the results of this study show that, for most patients, this therapy may not work.

"If early treatment of acute ischemic stroke with an anticoagulant like heparin does not help," says Harold P. Adams, Jr., M.D., principal investigator of the study and a professor of neurology at the University of Iowa College of Medicine in Iowa City, "then we should be treating patients with other therapies."

The study, called the Trial of Org 10172 in Acute Stroke Treatment (TOAST), was a 7-year, randomized, double-blind, placebo-controlled, multi-center study of 1,281 acute stroke patients in 36 centers across the United States. TOAST, sponsored by the National Institute of Neurological Disorders and Stroke (NINDS), is the largest trial of an intravenously administered anticoagulant drug for treatment of acute ischemic stroke.

The purpose of the trial was to discover the effectiveness of LMW heparinoid (danaparoid/Org 10172) combined with conventional care in improving outcomes of stroke patients at 7 days and at 3 months after stroke in comparison to conventional therapy alone. Conventional or usual management includes individualized treatment recommended by a patient?s doctor, such as other medications, surgery, and/or rehabilitation including speech therapy or physical therapy.

The researchers found that at 7 days, patients
'"/>

Contact: Marcia Vital
301/496-5751
NIH/National Institute of Neurological Disorders and Stroke
21-Apr-1998


Page: 1 2 3

Related medicine news :

1. Widely used breast cancer drug not linked to stroke
2. Widely used treatment for head injuries found to be harmful
3. Widely used anti-nausea drug may interfere with cancer chemotherapy
4. Widely used anti-bacterial inhibits parasites that cause malaria and toxoplasmosis
5. Newest Depression Medications Widely Prescribed For Children
6. Personality, Thought To Be Stable Over Time, Changes In Healthy People Who Take A Widely Used Anti-Depressant
7. UT Southwestern Moncrief Cancer Center is first in Texas to treat patients with TomoTherapy
8. Therapy, medication combination superior for children with obsessive-compulsive disorder
9. Oncology Nursing Society honors Fox Chase Cancer Center nurse with Radiation Therapy Nursing Award
10. Therapy for mice with prion disease could offer benefit to human beings with CJD
11. Vagus Nerve Stimulation Therapy (TM) more effective in epilepsy patients when used earlier

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/16/2019)... ... June 14, 2019 , ... ... Security solutions, today announced it has received the coveted “2019 Best DLP Solution ... that Works Platform along with the latest additions to its Data Security Portfolio ...
(Date:6/14/2019)... , ... June 14, 2019 , ... ... Tempur-Pedic® Mattress & Pink Bag Event® scheduled for Saturday, July 13th. UBCF is ... men and children directly impacted by breast cancer. This second event was added ...
(Date:6/13/2019)... ... June 13, 2019 , ... MMJ BioPharma Cultivation, a premier ... memorandum of understanding (MOU) with MMJ International Holdings to grow cannabis and supply ... BioPharma Cultivation will be supplying MMJIH with extracts from the marijuana plant to ...
(Date:6/13/2019)... ... June 13, 2019 , ... Pure Ratios, the ... cannabis delivery company, Driven Deliveries, Inc., the only publicly traded cannabis delivery service ... the population of California with overnight cannabis delivery to major thriving markets such ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... everyone in healthcare, today announced that Jon Elwell, the company’s CEO, has been ... DirectTrust is a non-profit health care industry alliance created to support ...
Breaking Medicine News(10 mins):
(Date:6/13/2019)... ... June 13, 2019 , ... Homecare Homebase ... the new Smart Scheduling product, part of the HCHB Intelligence Suite, at the ... uses complex algorithms to create highly efficient routing, mapping and scheduling for home ...
(Date:6/13/2019)... ... 13, 2019 , ... Access Healthcare , a leading provider of healthcare ... at the HFMA Annual Conference 2019 which will be held on June ... Access Healthcare, says, “HFMA Annual Conference has inspired us in many ways – right ...
(Date:6/13/2019)... ... , ... RxNT announced today that it has been named by ... RxNT is a leader in healthcare technology solutions. This is the fourth time RxNT ... highlight the best software products from North American small businesses. RxNT won the FrontRunner ...
Breaking Medicine Technology:
Cached News: